ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 240 out of 780

$788K Total Retail Price of All Prescriptions

Rank: 128 out of 780

533 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 9,364 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LOSARTAN POTASSIUM 582 503 1 18
METFORMIN HCL ER 527 429 2 43
HYDROCODONE-ACETAMINOPHEN 477 333 S3 3 1
SIMVASTATIN 415 353 4 2
LEVOTHYROXINE SODIUM 392 357 5 5
AMLODIPINE BESYLATE 377 311 6 4
CARVEDILOL 373 333 7 14
OMEPRAZOLE 336 270 8 3
ATORVASTATIN CALCIUM 323 275 9 12
LISINOPRIL 312 238 10 6
FUROSEMIDE 246 216 11 7
LOSARTAN-HYDROCHLOROTHIAZIDE 244 220 12 33
ZOLPIDEM TARTRATE 229 166 13 17
GABAPENTIN 184 154 14 13
TRAZODONE HCL 176 158 15 35
METFORMIN HCL 170 155 16 8
ALLOPURINOL 167 149 17 29
VICTOZA 3-PAK 162 119 18 313
CITALOPRAM HBR 152 129 19 23
TRAMADOL HCL 148 119 20 15
GLIMEPIRIDE 137 121 21 30
MELOXICAM 133 84 22 16
TIZANIDINE HCL 125 62 23 82
FENOFIBRATE 122 100 24 63
CRESTOR 112 93 25 32
PEN NEEDLE 110 83 26 136
BUPROPION XL 110 89 26 177
HYDRALAZINE HCL 108 88 28 54
HYDROCHLOROTHIAZIDE 107 86 29 10
SPIRONOLACTONE 102 88 30 53
POLYETHYLENE GLYCOL 3350 87 77 31 79
POTASSIUM CHLORIDE 87 85 31 11
ALENDRONATE SODIUM 86 68 33 44
RANITIDINE HCL 80 73 34 39
BENAZEPRIL HCL 79 71 35 59
BISOPROLOL FUMARATE 74 56 36 143
KLOR-CON 10 66 52 37 90
TRIAMTERENE-HCTZ 65 59 38 37
TAMSULOSIN HCL 65 61 38 36
DONEPEZIL HCL 63 56 40 31
CYMBALTA 62 38 41 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 52 41 26
LOVAZA 60 46 43 183
PLAVIX 60 54 43 45
CLOPIDOGREL 58 53 45 34
PRAVASTATIN SODIUM 58 47 45 9
KLOR-CON M20 57 48 47 57
PREDNISONE 56 53 48 40
PANTOPRAZOLE SODIUM 56 54 48 25
AMITRIPTYLINE HCL 55 23 R 50 48
NAMENDA 55 55 50 46
SYNTHROID 55 52 50 77
CLONIDINE HCL 54 22 53 28
WARFARIN SODIUM 54 47 53 24
LABETALOL HCL 53 42 55 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.